시린지 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Syringe was estimated to be worth US$ 10335 million in 2024 and is forecast to a readjusted size of US$ 13179 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Syringe cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A syringe is a medical device used for administering drugs or extracting body fluids, widely applied in vaccination, drug infusion, clinical blood sampling, and laboratory operations. Standard syringes consist of a needle, barrel, plunger, and safety protection mechanisms, emphasizing sterility, single-use, and ease of operation to minimize infection and cross-contamination risks. As healthcare services extend to primary care and community settings, innovative products such as prefilled syringes, auto-retractable syringes, and micro-injection devices are increasingly adopted, balancing safety, patient comfort, and precise dosage control. Leading manufacturers globally optimize costs through smart manufacturing and large-scale operations, while adhering to ISO, FDA, and national medical device regulations, ensuring product reliability and compliance in high-intensity usage scenarios. Technological upgrades and product iterations in the syringe industry directly support vaccination, chronic disease management, and in vitro diagnostics, underpinning rapid market expansion and providing foundational support to global healthcare systems.In 2024, global syringe production reached approximately 84.12 billion units, with an average global market price of around US$ 122.9 per k unit.

The global syringe market is driven by rising vaccination volumes, expanding chronic disease management needs, and public healthcare system development. COVID-19 vaccination campaigns and seasonal influenza vaccination programs have created long-term, inelastic demand through government procurement and public health initiatives, stimulating capacity expansion and technological innovation. The growing chronic disease patient population, particularly for diabetes, anticoagulation, and biologic drug injections, provides market opportunities for prefilled and smart syringes. Leading international and domestic manufacturers leverage automated production, precision molding, and intelligent inspection to enhance product consistency and safety while reducing unit costs and strengthening competitiveness. Policy support for primary care, telemedicine, and home healthcare further promotes syringe penetration in community and home settings. Global supply chain integration and increasing OEM/ODM collaborations support cross-regional market expansion and capital growth, establishing long-term growth momentum.Despite strong demand, the syringe industry faces multiple challenges. Regulatory compliance is increasingly stringent, requiring substantial investment to meet FDA, CE, and ISO certifications, raising operational costs. The industry is highly fragmented, with intense price competition in the low-end market limiting profit margins, forcing companies to rely on technological innovation and brand building for differentiation. Raw material price volatility, rising logistics costs, and international trade uncertainties increase supply chain risk, particularly during peak vaccination periods and public health emergencies, requiring effective production continuity and inventory management. Additionally, tightening environmental regulations regarding plastic syringe disposal and recycling increase long-term operational costs and risk management challenges.Downstream syringe demand is becoming more diversified, personalized, and high-end. Traditional hospitals and laboratories remain core markets, but rapid growth in home self-management, community healthcare, and telemedicine services is driving adoption of prefilled, micro, and smart syringes. Continuous vaccination campaigns, normalized chronic disease injections, and expansion of in vitro diagnostics jointly support long-term stable demand. Healthcare digitalization integrates syringes with wearable devices, remote monitoring systems, and cloud-based data platforms, enabling closed-loop management and precise dose tracking, improving patient experience and safety. Companies are gradually transforming from single consumable suppliers to comprehensive injection solution providers, unlocking new incremental markets and long-term commercial value.

This report aims to provide a comprehensive presentation of the global market for Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Syringe by region & country, by Type, and by Application.

The Syringe market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Syringe.

Market Segmentation

By Company

• BD
• Embecta
• Terumo
• Weigao Medical
• Cardinal Health
• Nipro
• B.Braun
• ICU Medical
• Kandlai
• Double Pigeon Group
• Bridge Group
• Feel Tech
• Jiangsu Zhengkang Medical
• Shuguang Huizhikang
• Jiangsu Jichun Medical Equipment
• Sanxin Medical
• Shengguang Group
• Hongda Medical
• Anhui Hongyu Wuzhou
• Caina Medical

Segment by Type

• Conventional Syringe
• Safety Syringe

Segment by Application

• Medical
• Non-medical

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Syringe Product Introduction
• 1.2 Global Syringe Market Size Forecast
  • 1.2.1 Global Syringe Sales Value (2020-2031)
  • 1.2.2 Global Syringe Sales Volume (2020-2031)
  • 1.2.3 Global Syringe Sales Price (2020-2031)
• 1.3 Syringe Market Trends & Drivers
  • 1.3.1 Syringe Industry Trends
  • 1.3.2 Syringe Market Drivers & Opportunity
  • 1.3.3 Syringe Market Challenges
  • 1.3.4 Syringe Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Syringe Players Revenue Ranking (2024)
• 2.2 Global Syringe Revenue by Company (2020-2025)
• 2.3 Global Syringe Players Sales Volume Ranking (2024)
• 2.4 Global Syringe Sales Volume by Company Players (2020-2025)
• 2.5 Global Syringe Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Syringe Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Syringe Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Syringe
• 2.9 Syringe Market Competitive Analysis
  • 2.9.1 Syringe Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Syringe Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Syringe as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Conventional Syringe
  • 3.1.2 Safety Syringe
• 3.2 Global Syringe Sales Value by Type
  • 3.2.1 Global Syringe Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Syringe Sales Value, by Type (2020-2031)
  • 3.2.3 Global Syringe Sales Value, by Type (%) (2020-2031)
• 3.3 Global Syringe Sales Volume by Type
  • 3.3.1 Global Syringe Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Syringe Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Syringe Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Syringe Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Medical
  • 4.1.2 Non-medical
• 4.2 Global Syringe Sales Value by Application
  • 4.2.1 Global Syringe Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Syringe Sales Value, by Application (2020-2031)
  • 4.2.3 Global Syringe Sales Value, by Application (%) (2020-2031)
• 4.3 Global Syringe Sales Volume by Application
  • 4.3.1 Global Syringe Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Syringe Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Syringe Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Syringe Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Syringe Sales Value by Region
  • 5.1.1 Global Syringe Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Syringe Sales Value by Region (2020-2025)
  • 5.1.3 Global Syringe Sales Value by Region (2026-2031)
  • 5.1.4 Global Syringe Sales Value by Region (%), (2020-2031)
• 5.2 Global Syringe Sales Volume by Region
  • 5.2.1 Global Syringe Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Syringe Sales Volume by Region (2020-2025)
  • 5.2.3 Global Syringe Sales Volume by Region (2026-2031)
  • 5.2.4 Global Syringe Sales Volume by Region (%), (2020-2031)
• 5.3 Global Syringe Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Syringe Sales Value, 2020-2031
  • 5.4.2 North America Syringe Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Syringe Sales Value, 2020-2031
  • 5.5.2 Europe Syringe Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Syringe Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Syringe Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Syringe Sales Value, 2020-2031
  • 5.7.2 South America Syringe Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Syringe Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Syringe Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Syringe Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Syringe Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Syringe Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Syringe Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Syringe Sales Value, 2020-2031
  • 6.3.2 United States Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Syringe Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Syringe Sales Value, 2020-2031
  • 6.4.2 Europe Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Syringe Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Syringe Sales Value, 2020-2031
  • 6.5.2 China Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Syringe Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Syringe Sales Value, 2020-2031
  • 6.6.2 Japan Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Syringe Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Syringe Sales Value, 2020-2031
  • 6.7.2 South Korea Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Syringe Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Syringe Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Syringe Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Syringe Sales Value, 2020-2031
  • 6.9.2 India Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Syringe Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 BD
  • 7.1.1 BD Company Information
  • 7.1.2 BD Introduction and Business Overview
  • 7.1.3 BD Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 BD Syringe Product Offerings
  • 7.1.5 BD Recent Development
• 7.2 Embecta
  • 7.2.1 Embecta Company Information
  • 7.2.2 Embecta Introduction and Business Overview
  • 7.2.3 Embecta Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Embecta Syringe Product Offerings
  • 7.2.5 Embecta Recent Development
• 7.3 Terumo
  • 7.3.1 Terumo Company Information
  • 7.3.2 Terumo Introduction and Business Overview
  • 7.3.3 Terumo Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Terumo Syringe Product Offerings
  • 7.3.5 Terumo Recent Development
• 7.4 Weigao Medical
  • 7.4.1 Weigao Medical Company Information
  • 7.4.2 Weigao Medical Introduction and Business Overview
  • 7.4.3 Weigao Medical Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Weigao Medical Syringe Product Offerings
  • 7.4.5 Weigao Medical Recent Development
• 7.5 Cardinal Health
  • 7.5.1 Cardinal Health Company Information
  • 7.5.2 Cardinal Health Introduction and Business Overview
  • 7.5.3 Cardinal Health Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Cardinal Health Syringe Product Offerings
  • 7.5.5 Cardinal Health Recent Development
• 7.6 Nipro
  • 7.6.1 Nipro Company Information
  • 7.6.2 Nipro Introduction and Business Overview
  • 7.6.3 Nipro Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Nipro Syringe Product Offerings
  • 7.6.5 Nipro Recent Development
• 7.7 B.Braun
  • 7.7.1 B.Braun Company Information
  • 7.7.2 B.Braun Introduction and Business Overview
  • 7.7.3 B.Braun Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 B.Braun Syringe Product Offerings
  • 7.7.5 B.Braun Recent Development
• 7.8 ICU Medical
  • 7.8.1 ICU Medical Company Information
  • 7.8.2 ICU Medical Introduction and Business Overview
  • 7.8.3 ICU Medical Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 ICU Medical Syringe Product Offerings
  • 7.8.5 ICU Medical Recent Development
• 7.9 Kandlai
  • 7.9.1 Kandlai Company Information
  • 7.9.2 Kandlai Introduction and Business Overview
  • 7.9.3 Kandlai Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Kandlai Syringe Product Offerings
  • 7.9.5 Kandlai Recent Development
• 7.10 Double Pigeon Group
  • 7.10.1 Double Pigeon Group Company Information
  • 7.10.2 Double Pigeon Group Introduction and Business Overview
  • 7.10.3 Double Pigeon Group Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Double Pigeon Group Syringe Product Offerings
  • 7.10.5 Double Pigeon Group Recent Development
• 7.11 Bridge Group
  • 7.11.1 Bridge Group Company Information
  • 7.11.2 Bridge Group Introduction and Business Overview
  • 7.11.3 Bridge Group Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Bridge Group Syringe Product Offerings
  • 7.11.5 Bridge Group Recent Development
• 7.12 Feel Tech
  • 7.12.1 Feel Tech Company Information
  • 7.12.2 Feel Tech Introduction and Business Overview
  • 7.12.3 Feel Tech Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Feel Tech Syringe Product Offerings
  • 7.12.5 Feel Tech Recent Development
• 7.13 Jiangsu Zhengkang Medical
  • 7.13.1 Jiangsu Zhengkang Medical Company Information
  • 7.13.2 Jiangsu Zhengkang Medical Introduction and Business Overview
  • 7.13.3 Jiangsu Zhengkang Medical Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Jiangsu Zhengkang Medical Syringe Product Offerings
  • 7.13.5 Jiangsu Zhengkang Medical Recent Development
• 7.14 Shuguang Huizhikang
  • 7.14.1 Shuguang Huizhikang Company Information
  • 7.14.2 Shuguang Huizhikang Introduction and Business Overview
  • 7.14.3 Shuguang Huizhikang Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Shuguang Huizhikang Syringe Product Offerings
  • 7.14.5 Shuguang Huizhikang Recent Development
• 7.15 Jiangsu Jichun Medical Equipment
  • 7.15.1 Jiangsu Jichun Medical Equipment Company Information
  • 7.15.2 Jiangsu Jichun Medical Equipment Introduction and Business Overview
  • 7.15.3 Jiangsu Jichun Medical Equipment Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Jiangsu Jichun Medical Equipment Syringe Product Offerings
  • 7.15.5 Jiangsu Jichun Medical Equipment Recent Development
• 7.16 Sanxin Medical
  • 7.16.1 Sanxin Medical Company Information
  • 7.16.2 Sanxin Medical Introduction and Business Overview
  • 7.16.3 Sanxin Medical Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Sanxin Medical Syringe Product Offerings
  • 7.16.5 Sanxin Medical Recent Development
• 7.17 Shengguang Group
  • 7.17.1 Shengguang Group Company Information
  • 7.17.2 Shengguang Group Introduction and Business Overview
  • 7.17.3 Shengguang Group Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Shengguang Group Syringe Product Offerings
  • 7.17.5 Shengguang Group Recent Development
• 7.18 Hongda Medical
  • 7.18.1 Hongda Medical Company Information
  • 7.18.2 Hongda Medical Introduction and Business Overview
  • 7.18.3 Hongda Medical Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 Hongda Medical Syringe Product Offerings
  • 7.18.5 Hongda Medical Recent Development
• 7.19 Anhui Hongyu Wuzhou
  • 7.19.1 Anhui Hongyu Wuzhou Company Information
  • 7.19.2 Anhui Hongyu Wuzhou Introduction and Business Overview
  • 7.19.3 Anhui Hongyu Wuzhou Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Anhui Hongyu Wuzhou Syringe Product Offerings
  • 7.19.5 Anhui Hongyu Wuzhou Recent Development
• 7.20 Caina Medical
  • 7.20.1 Caina Medical Company Information
  • 7.20.2 Caina Medical Introduction and Business Overview
  • 7.20.3 Caina Medical Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Caina Medical Syringe Product Offerings
  • 7.20.5 Caina Medical Recent Development

8 Industry Chain Analysis

• 8.1 Syringe Industrial Chain
• 8.2 Syringe Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Syringe Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Syringe Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer